Aegle Therapeutics Corporation, a first-in-class biotechnology company developing extracellular vesicles as therapy, today announced the completion of a $6.5M Series A round of financing.
Aegle is also pleased to announce the appointment of Heidi Kempinski as Senior Vice President, Head of Operations…
